Clinical Trial Update: Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing moxifloxacin plus metronidazole versus piperacillin/tazobactam for intra-abdominal abscesses; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Abscess

Drugs mentioned

• METRONIDAZOLE (Metronidazole)
• Moxifloxacin (moxifloxacin)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Hannover Medical School | Conditions: Abscess, Intra-Abdominal | Phase 3 | Status: COMPLETED